CClinicalTrials.gg
CompletedNCT03570515Updated Jul 11, 2023

Yoga vs. Education for Restless Legs Syndrome: a Feasibility Study

An interventional study of Yoga and Educational film in Restless Legs Syndrome, sponsored by West Virginia University. Completed at 1 site in United States. Open to participants aged 21 Years and older. Per ClinicalTrials.gov, last updated 2023-07-11.

Sponsored by West Virginia University · Not applicable, Interventional, and Other

From the registry’s dates

  • Registered 1 year 11 months after the study started (first participant enrolled Feb 2015, registered Feb 2017).
Phase
Not applicable
Study type
Interventional
Enrollment
41
Allocation
Randomized
Ages
21 Years and older
Sex
All
01

Study summary

The purpose of this study is to see whether adults with Restless Legs Syndrome (RLS) are willing to be in a 12-week study where they have a 50-50 chance of being placed in either a gentle yoga program or a film-based education program designed for people with RLS. If so, do they complete the program, and does their RLS, sleep, mood, or quality of life improve?

02

Conditions studied

03

In context

Psychomotor Agitation

500 studies on the registry are indexed under Psychomotor Agitation; 55 are open to participants now.

This study's enrollment of 41 is below the median of 90 across 413 interventional studies indexed under Psychomotor Agitation.

Browse Psychomotor Agitation studies →

Lead sponsor

West Virginia University is the lead sponsor of 155 studies on the registry; 35 are open to participants now.

Of its 19 completed or terminated interventional studies of FDA-regulated products, 16 (84%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
21 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • ambulatory adults
  • at least 21 years of age
  • moderate-severe RLS, defined as:

    1. symptoms that meet all five of the International RLS Study Group essential diagnostic criteria for RLS (i.e., 1) an urge to move the legs, often associated with discomfort or disagreeable sensations in the legs, that 2) begins or worsen during periods of rest or inactivity; 3) is partially or totally relieved by movement; 4) is worse or only occurs in the evening or night; and 5) is not solely accounted for by another condition (e.g. leg cramps, positional discomfort, habitual foot tapping));
    2. RLS symptoms at least 1x/wk for the previous 3 months;
    3. a score of at least 2 points (moderate) IRLS question 6: "How severe was your RLS as a whole?"; and
    4. RLS diagnostic criteria applied as per training by the study physician, a sleep medicine expert; these criteria will help ensure exclusion of mimics (e.g. leg cramps, positional discomfort).
  • willingness and ability to complete the 12-week yoga or educational film program and all study assessments;
  • willingness to avoid use of any new drugs or treatments other than the assigned intervention.

Exclusion criteria

Exclusion Criteria:

  • practiced yoga within the past year;
  • currently on dopaminergic agents (eg, ropinirole, pramipexole) or anti-psychotic medication;
  • changed dosage if any other central nervous system agents (e.g., sedative hypnotics, gamma-aminobutyric acid (GABA) analogs, narcotic analgesics, antiadrenergic agents, or anticonvulsants) within the past 3 months;
  • any orthopedic, neurologic or other condition that might prevent safe completion of a 12-week yoga program or confound assessments (e.g., neuropathy; Parkinson's disease; stroke; rheumatoid arthritis; renal failure; uncontrolled sleep apnea; recent (within the last 6 months) myocardial infarction; heart failure; cancer (other than non-melanoma skin cancer);
  • pregnant or within 6 months post-partum).
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Investigator, Outcomes assessor)
Enrollment
41 participants (actual)

Study arms

  • Experimental
    Yoga

    Yoga group participants will attend two, 75-minute yoga classes/week for 4 weeks, then one class/week for 8 weeks, and do a 30-minute home practice on non-class days.

    Behavioral: Yoga

  • Active comparator
    Educational Film

    Educational film group participants will attend one, 75-minute film class/week for 12 weeks, recording any RLS treatments they use at home.

    Behavioral: Educational film

Interventions

  • BehavioralYoga

    Yoga group participants will attend two, 75-minute yoga classes/week for 4 weeks, then one class/week for 8 weeks, and do a 30-minute home practice on non-class days, recording their practice on a yoga homework log provided to them.

  • BehavioralEducational film

    Educational film group participants will attend one, 75-minute film class/week for 12 weeks, recording any RLS treatments they use at home.

06

What researchers measure

Primary outcomes

  1. Recruitment rate

    To determine feasibility and acceptability of the programs, we will collect comprehensive information, both overall and by treatment group, on: rates of recruitment and success of different recruitment strategies, and reasons for refusal to participate.

    Time frame: 12 weeks

  2. Retention rates

    To determine feasibility and acceptability of the programs, we will collect comprehensive information, both overall and by treatment group, on: rates of retention (completion of assessment visits)

    Time frame: 12 weeks

  3. Adherence rates

    To determine feasibility and acceptability of the programs, we will collect comprehensive information, both overall and by treatment group, on rates of adherence (completion of home logs and class attendance rates (yoga and film groups); completion of home practice (yoga group));

    Time frame: 12 weeks

  4. Participant satisfaction

    To determine feasibility and acceptability of the programs, we will collect comprehensive information, both overall and by treatment group, on participant satisfaction, assessed via a structured program evaluation questionnaire regarding participant perceptions of and experiences with the study, and satisfaction regarding their respective programs

    Time frame: 12 weeks

Secondary outcomes

  1. Yoga dosing preference

    A structured questionnaire regarding possible yoga dosing scenarios will be administered at week 12 to determine participant preferences relative to yoga programs of varying duration and intensity (8 weeks, 16 classes (2x/week); 12 weeks, 16 classes (2x/week for the first 4 weeks, once/week thereafter); 16 weeks, 16 classes (once/week), as well as time of year the classes meet. Information from this questionnaire will aid in optimizing the yoga protocol for our future studies.

    Time frame: 12 weeks

  2. International RLS Rating Scale (IRLS)

    To determine effect sizes of the programs, data critical to the design of the planned larger randomized clinical trial. RLS symptom severity, the primary efficacy outcome for the full scale trial, will be evaluated using the IRLS, a 10 item scale which includes questions related to frequency, intensity, and impact.

    Time frame: 12 weeks

  3. Pittsburgh Sleep Quality Index (PSQI)

    Sleep quality will be assessed using the 9-item PSQI

    Time frame: 12 weeks

  4. Profile of Mood States (POMS)

    Mood will be evaluated using the 65-item POMS

    Time frame: 12 weeks

  5. Perceived Stress Scale (PSS)

    10-item PSS

    Time frame: 12 weeks

  6. Medical Outcomes Study Short Form-36 (SF-36).

    Health-related quality of life will be measured using the 36-item SF-36.

    Time frame: 12 weeks

07

Study locations

1 site
  • West Virginia University
    Morgantown, West Virginia 26506, United States
08

References and documents

Publications

  • Selfe TK, Montgomery C, Klatt M, Wen S, Sherman KJ, Innes KE. An Exploratory Randomized Controlled Trial of a 12-Week Yoga Versus Educational Film Program for the Management of Restless Legs Syndrome: Feasibility and Acceptability. J Integr Complement Med. 2022 Apr;28(4):309-319. doi: 10.1089/jicm.2021.0182. Epub 2022 Jan 18. PubMed 35426733 ↗
  • Innes KE, Selfe TK, Montgomery C, Hollingshead N, Huysmans Z, Srinivasan R, Wen S, Hausmann MJ, Sherman K, Klatt M. Effects of a 12-week yoga versus a 12-week educational film intervention on symptoms of restless legs syndrome and related outcomes: an exploratory randomized controlled trial. J Clin Sleep Med. 2020 Jan 15;16(1):107-119. doi: 10.5664/jcsm.8134. PubMed 31957638 ↗
  • Selfe TK, Wen S, Sherman K, Klatt M, Innes KE. Acceptability and feasibility of a 12-week yoga vs. educational film program for the management of restless legs syndrome (RLS): study protocol for a randomized controlled trial. Trials. 2019 Feb 15;20(1):134. doi: 10.1186/s13063-019-3217-7. PubMed 30770767 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 11, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03570515
Lead sponsor
West Virginia University
Responsible party
Sponsor
First posted
Jun 27, 2018
Start date
Feb 15, 2015
Primary completion
Jul 15, 2019
Completion
Aug 15, 2021
Last update
Jul 11, 2023

Study contacts

Kim E Innes, PhD
principal investigator · WVU

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion